Home
This Title All WIREs
WIREs RSS Feed
How to cite this WIREs title:
WIREs Nanomed Nanobiotechnol
Impact Factor: 6.14

Top‐down particle fabrication: control of size and shape for diagnostic imaging and drug delivery

Full article on Wiley Online Library:   HTML PDF

Can't access this content? Tell your librarian.

Abstract This review discusses rational design of particles for use as therapeutic vectors and diagnostic imaging agent carriers. The emerging importance of both particle size and shape is considered, and the adaptation and modification of soft lithography methods to produce nanoparticles are highlighted. To this end, studies utilizing particles made via a process called Particle Replication In Non‐wetting Templates are discussed. In addition, insights gained into therapeutic cargo and imaging agent delivery from related types of polymer‐based carriers are considered. Copyright © 2009 John Wiley & Sons, Inc. This article is categorized under: Therapeutic Approaches and Drug Discovery > Emerging Technologies

Schematic representation of the Particle Replication In Non‐wetting Templates PRINT process. (a) Empty mold (green) high‐surface‐energy polymer sheet (clear) roller (black) is brought into contact with the particle precursor solution (red) and the mold; (b) Roller evenly distributes particle precursor solution into the cavities of mold. Excess particle precursor solution is wicked away by the high‐surface‐energy polymer sheet; (c) Particles are cured in the mold; (d) Particles are removed from the mold; (e) Particles are collected or harvested using a number of different film‐based techniques and ultimately are dispersed in solution. (Reprinted with permission. Copyright 2008. American Chemical Society)

[ Normal View | Magnified View ]

T1‐weighted MR images a bolus injection of 200 × 200 nm cylindrical particles (a) just before (b) and 60 min post (c) injection.

[ Normal View | Magnified View ]

Magneto polymer composite polymer particles of well‐defined size and shape prepared via the PRINT process: (a) SEM image of 200 × 200 nm cylinders, (b) SEM image of 2 × 2 × 2 µm cubes (c) TEM of biocompatible 200 × 200 nm particle containing 15 wt% PEG silane coated iron oxide nanocrystals, and (d) T2 phantom study of iron oxide containing particles in agarose gel. Equimolar concentrations of PRINT particles with increasing iron oxide loading.

[ Normal View | Magnified View ]

Scanning electron micrographs and 3D illustrations of poly (styrene) (PS) particles created for phagocytosis experiments. (a) Spheres, (b) oblate ellipsoids (13%), (c) prolate ellipsoids (7%), (d) elliptical disks (9%), (e) rectangular disks (5%), and (f) UFOs (12%). Particles are monodispersed with average standard deviations of measured dimensions for each shape listed in parentheses. A portion of this variation is due to 2–5%standard deviation in the diameter of spheres used as starting materials. Scale bars = 5 µm. (Reprinted with permission from Ref 60. Copyright 2006 National Academy of Scineces USA).

[ Normal View | Magnified View ]

SEM images of S‐FIL imprinted (100% w/v, MW 3400) PEG‐diacrylate (PEGDA) nanoparticles: (a) 50 nm squares (scale bar = 100 nm), (b) 100 nm squares (scale bar = 200 nm), (c) 200 nm squares (scale bar = 300 nm), (d) 200 nm triangles (scale bar = 200 nm), (e) 400 nm triangles (scale bar = 300 nm), and (f) 400 nm pentagonal particles (scale bar = 200 nm). (Reprinted with permission from Ref 66. Copyright 2008 Elsevier).

[ Normal View | Magnified View ]

Transmission electron microscopy (TEM) image showing HeLa cell internalization of 150 × 450 nm (top) or 200 × 200 nm (bottom) cylindrical particles fabricated via the PRINT process. (Reprinted with permission from Ref 44. Copyright 2008 National Academy of Science USA).

[ Normal View | Magnified View ]

MicroPET imaging with 64Cu–DOTA PRINT particles. Time‐resolved PET images consisting of a 2‐h dynamic scan. The PET/CT images are overlayed. Mouse was injected with 136.2µCi of 64Cu‐labeled DOTA nanoparticles. Both the coronal view (top), and sagittal view (bottom) are presented. (Reprinted with permission from Ref 45. Copyright 2008 American Chemical Society).

[ Normal View | Magnified View ]

scanning electron microscope (SEM) images of particles of various sizes, shapes, and compositions prepared via the PRINT process: (a) Hydrogel rods containing antisense oligonucleotide; (b) crosslinked degradable matrix cubes containing doxorubicin HCl; (c) Abraxane harvested onto medical adhesive; (d) Insulin particles harvested onto a medical adhesive; (e) Hydrogel ‘boomerangs’ containing 15 wt% iron oxide; (f) Hydrogel cylinders containing 10 wt% Omniscan. (Reprinted with permission from Ref 47. Copyright 2008 (b), Ref 48 Copyright 2008 (c, d) and Ref 46. Copyright 2007 (e) American Chemical Society).

[ Normal View | Magnified View ]

Continuous thin mold manufacturing for the PRINT process. Patterned surface can be seen in green. (Reprinted with permission from Ref 71. Liquidia Technologies.).

[ Normal View | Magnified View ]

Related Articles

Magnetic resonance relaxation properties of superparamagnetic particles

Browse by Topic

Therapeutic Approaches and Drug Discovery > Emerging Technologies

Access to this WIREs title is by subscription only.

Recommend to Your
Librarian Now!

The latest WIREs articles in your inbox

Sign Up for Article Alerts